期刊文献+

去白细胞单采血小板的临床应用 被引量:3

Clinical Application of Apheresis Platelets with Leukocyte Filtration
下载PDF
导出
摘要 【目的】研究保存前白细胞过滤与保存后白细胞过滤对单采血小板临床输注效果及非溶血性发热输血反应(FNHTR)发生率的影响。【方法】46例肿瘤化疗后血小板减少患者,分别输注保存前过滤单采血小板(保存前组)与保存后过滤单采血小板(保存后组),输注后1 h及24 h后检测外周血小板计数,以校正血小板计数增殖(CCI)判定输注效果,并考查FNHTR发生率。【结果】保存前组与保存后组其1 h及24 h CCI值无明显差异(P>0.05),但保存前组FNHTR发生率要明显低于保存后组(P<0.05)。【结论】两种方法制备的单采血小板均能有效地治疗血小板减少,但保存前过滤能更有效地减少FNHTR的发生率。 [Objeetive]To study the effect of prestorage and poststorage leukocyte filtration on apheresis platelets transfusion and the incidence rate of febrile nonhemolytic transfusion reactions(FNHTR). [Methods] Prestorage (Prestorage group) and poststorage (Poststorage group) leukocyte filtration apheresis platelets were transfused respectively to patients with malignancy accompanied by serious thrombocytopenia after chemotherapy. Peripheral blood platelet counts were made at lh, 24h after platelet transfusion. The effectiveness was assayed by correct count increment (CCI). The incidence rates of FNHTR were explored. [Results]The lh and 24h CCI between prestorage and poststorage groups were of no difference( P〉0. 05), but the incidence rate of FNGTR of poststorage group was much higher than that of prestorage group( P〈0.05). [Conclusion] Apheresis platelets by both preparations show excellent transfusion results in curing thrombocytopenia, but prestorage leukocyte filtration can effectively reduce the incidence rate of FNHTR.
出处 《医学临床研究》 CAS 2005年第9期1195-1196,1199,共3页 Journal of Clinical Research
  • 相关文献

参考文献6

  • 1成晓玲,赵树铭,胡建,曾杰,任德惠,王泽荣,林武存.白细胞过滤对血小板保存期间炎性细胞因子水平的影响及临床效果的评估[J].中国输血杂志,2002,15(3):156-159. 被引量:13
  • 2张献清,张莉,李翠莹,李琳琳.不同剂量紫外线照射对血小板活化的影响[J].中国医学物理学杂志,1999,16(4):251-253. 被引量:7
  • 3Muller-steinhardt M, Schlenke P, Wagner T, et al . Transfusion of platelet concentrates from buffy-coats: comparison of bedside vs. prestorage leukofiltration [J]. Transfus Med ,2000, 10(1) :59-65.
  • 4Hartwig D, Hartel C, Hennig H, et al . Evidence for de novo synthesis of cytokines and chemokines in platelet concentrates[J]. Vox Sang , 2002,82(4):182-190.
  • 5Chalandon Y, Mermillod B, Beris P, et al . Benefit of prestorage leucocyte of single-donor platelet concentrates[J]. Vox Sang ,1999,76 (1) :27-37.
  • 6Hetland G, Mollnes TE, Bergh K, et al . Effect of filtration and storage of platelet concentrates on the production of the chemotaxins C3a, interleukin 8, tumor necrosis factor alpha, and leukotriene B4[J]. Transfusion , 1998,38(1):16-23.

二级参考文献2

共引文献18

同被引文献22

  • 1张义梅.糖尿病患者血小板功能与下肢血管病变之间关系的探讨[J].中国卫生统计,2006,23(5):471-471. 被引量:1
  • 2陈晓丹,李永莉,马宁,陈星群.临床成分输血分析[J].临床和实验医学杂志,2007,6(9):30-31. 被引量:4
  • 3Heddle NM, Barry RL, Sigouin CS, et al. In vitro evaluation of prestor- age pooled leukoreduced whole blood - derived platelets store for up to days[J]. Transfusion, 2005, 45(6):904-910.
  • 4Anderson NA, Gray S, Copplestone JA, et al. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reaction. Trans Med, 1996, 6(7): 33-39.
  • 5Chalandon Y, Mermillod B, Beris Ph, et al. Benefit of prestorage leukocyte depletion of single-donor platelet concentrates. Vox Sang, 1999, 76(1) :27-37.
  • 6Heddle NM, Klama L, Meyer R, et al. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion, 1999, 39 (3): 231- 238.
  • 7Heddle NM, Blajchman MA, Meyer RM, et al. A randomized controlled trial comparing the frequency of acute reactions toplasma-removed platelets and prestorage WBC-reduced platelets. Transfusion, 2002, 42(5) : 556-566.
  • 8Kliiter H, Bubel S, Kirchner H, et al. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion, 1999, 39 ( 11-12 ) : 1179- 1184.
  • 9Ogawa Y, Wakana M, Tanaka K, et al. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets. Vox Sang, 1998, 75(2):103-109.
  • 10Williamson LM, Wimperis JZ, Williamson P, et al. Bedside filtration of blood products in the prevention of HLA prospective randomized Group. Blood, 1994, 83(10) study. 3028.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部